table of content
1 Introduction to Research & Analysis Reports
1.1 Cancer (Tumor) Profiling Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cancer (Tumor) Profiling Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cancer (Tumor) Profiling Overall Market Size
2.1 Global Cancer (Tumor) Profiling Market Size: 2022 VS 2029
2.2 Global Cancer (Tumor) Profiling Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Cancer (Tumor) Profiling Players in Global Market
3.2 Top Global Cancer (Tumor) Profiling Companies Ranked by Revenue
3.3 Global Cancer (Tumor) Profiling Revenue by Companies
3.4 Top 3 and Top 5 Cancer (Tumor) Profiling Companies in Global Market, by Revenue in 2022
3.5 Global Companies Cancer (Tumor) Profiling Product Type
3.6 Tier 1, Tier 2 and Tier 3 Cancer (Tumor) Profiling Players in Global Market
3.6.1 List of Global Tier 1 Cancer (Tumor) Profiling Companies
3.6.2 List of Global Tier 2 and Tier 3 Cancer (Tumor) Profiling Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Cancer (Tumor) Profiling Market Size Markets, 2022 & 2029
4.1.2 Immunoassay
4.1.3 NGS
4.1.4 Mass Spectrometry
4.1.5 Others
4.2 By Type - Global Cancer (Tumor) Profiling Revenue & Forecasts
4.2.1 By Type - Global Cancer (Tumor) Profiling Revenue, 2018-2023
4.2.2 By Type - Global Cancer (Tumor) Profiling Revenue, 2024-2029
4.2.3 By Type - Global Cancer (Tumor) Profiling Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Cancer (Tumor) Profiling Market Size, 2022 & 2029
5.1.2 Clinical
5.1.3 Research
5.2 By Application - Global Cancer (Tumor) Profiling Revenue & Forecasts
5.2.1 By Application - Global Cancer (Tumor) Profiling Revenue, 2018-2023
5.2.2 By Application - Global Cancer (Tumor) Profiling Revenue, 2024-2029
5.2.3 By Application - Global Cancer (Tumor) Profiling Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Cancer (Tumor) Profiling Market Size, 2022 & 2029
6.2 By Region - Global Cancer (Tumor) Profiling Revenue & Forecasts
6.2.1 By Region - Global Cancer (Tumor) Profiling Revenue, 2018-2023
6.2.2 By Region - Global Cancer (Tumor) Profiling Revenue, 2024-2029
6.2.3 By Region - Global Cancer (Tumor) Profiling Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Cancer (Tumor) Profiling Revenue, 2018-2029
6.3.2 US Cancer (Tumor) Profiling Market Size, 2018-2029
6.3.3 Canada Cancer (Tumor) Profiling Market Size, 2018-2029
6.3.4 Mexico Cancer (Tumor) Profiling Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Cancer (Tumor) Profiling Revenue, 2018-2029
6.4.2 Germany Cancer (Tumor) Profiling Market Size, 2018-2029
6.4.3 France Cancer (Tumor) Profiling Market Size, 2018-2029
6.4.4 U.K. Cancer (Tumor) Profiling Market Size, 2018-2029
6.4.5 Italy Cancer (Tumor) Profiling Market Size, 2018-2029
6.4.6 Russia Cancer (Tumor) Profiling Market Size, 2018-2029
6.4.7 Nordic Countries Cancer (Tumor) Profiling Market Size, 2018-2029
6.4.8 Benelux Cancer (Tumor) Profiling Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Cancer (Tumor) Profiling Revenue, 2018-2029
6.5.2 China Cancer (Tumor) Profiling Market Size, 2018-2029
6.5.3 Japan Cancer (Tumor) Profiling Market Size, 2018-2029
6.5.4 South Korea Cancer (Tumor) Profiling Market Size, 2018-2029
6.5.5 Southeast Asia Cancer (Tumor) Profiling Market Size, 2018-2029
6.5.6 India Cancer (Tumor) Profiling Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Cancer (Tumor) Profiling Revenue, 2018-2029
6.6.2 Brazil Cancer (Tumor) Profiling Market Size, 2018-2029
6.6.3 Argentina Cancer (Tumor) Profiling Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Cancer (Tumor) Profiling Revenue, 2018-2029
6.7.2 Turkey Cancer (Tumor) Profiling Market Size, 2018-2029
6.7.3 Israel Cancer (Tumor) Profiling Market Size, 2018-2029
6.7.4 Saudi Arabia Cancer (Tumor) Profiling Market Size, 2018-2029
6.7.5 UAE Cancer (Tumor) Profiling Market Size, 2018-2029
7 Cancer (Tumor) Profiling Companies Profiles
7.1 Illumina
7.1.1 Illumina Company Summary
7.1.2 Illumina Business Overview
7.1.3 Illumina Cancer (Tumor) Profiling Major Product Offerings
7.1.4 Illumina Cancer (Tumor) Profiling Revenue in Global Market (2018-2023)
7.1.5 Illumina Key News & Latest Developments
7.2 Qiagen
7.2.1 Qiagen Company Summary
7.2.2 Qiagen Business Overview
7.2.3 Qiagen Cancer (Tumor) Profiling Major Product Offerings
7.2.4 Qiagen Cancer (Tumor) Profiling Revenue in Global Market (2018-2023)
7.2.5 Qiagen Key News & Latest Developments
7.3 Neogenomics Laboratories
7.3.1 Neogenomics Laboratories Company Summary
7.3.2 Neogenomics Laboratories Business Overview
7.3.3 Neogenomics Laboratories Cancer (Tumor) Profiling Major Product Offerings
7.3.4 Neogenomics Laboratories Cancer (Tumor) Profiling Revenue in Global Market (2018-2023)
7.3.5 Neogenomics Laboratories Key News & Latest Developments
7.4 HTG Molecular Diagnostics
7.4.1 HTG Molecular Diagnostics Company Summary
7.4.2 HTG Molecular Diagnostics Business Overview
7.4.3 HTG Molecular Diagnostics Cancer (Tumor) Profiling Major Product Offerings
7.4.4 HTG Molecular Diagnostics Cancer (Tumor) Profiling Revenue in Global Market (2018-2023)
7.4.5 HTG Molecular Diagnostics Key News & Latest Developments
7.5 Genomic Health
7.5.1 Genomic Health Company Summary
7.5.2 Genomic Health Business Overview
7.5.3 Genomic Health Cancer (Tumor) Profiling Major Product Offerings
7.5.4 Genomic Health Cancer (Tumor) Profiling Revenue in Global Market (2018-2023)
7.5.5 Genomic Health Key News & Latest Developments
7.6 Caris Life Sciences
7.6.1 Caris Life Sciences Company Summary
7.6.2 Caris Life Sciences Business Overview
7.6.3 Caris Life Sciences Cancer (Tumor) Profiling Major Product Offerings
7.6.4 Caris Life Sciences Cancer (Tumor) Profiling Revenue in Global Market (2018-2023)
7.6.5 Caris Life Sciences Key News & Latest Developments
7.7 Helomics Corporation
7.7.1 Helomics Corporation Company Summary
7.7.2 Helomics Corporation Business Overview
7.7.3 Helomics Corporation Cancer (Tumor) Profiling Major Product Offerings
7.7.4 Helomics Corporation Cancer (Tumor) Profiling Revenue in Global Market (2018-2023)
7.7.5 Helomics Corporation Key News & Latest Developments
7.8 Nanostring Technologies
7.8.1 Nanostring Technologies Company Summary
7.8.2 Nanostring Technologies Business Overview
7.8.3 Nanostring Technologies Cancer (Tumor) Profiling Major Product Offerings
7.8.4 Nanostring Technologies Cancer (Tumor) Profiling Revenue in Global Market (2018-2023)
7.8.5 Nanostring Technologies Key News & Latest Developments
7.9 Oxford Gene Technology
7.9.1 Oxford Gene Technology Company Summary
7.9.2 Oxford Gene Technology Business Overview
7.9.3 Oxford Gene Technology Cancer (Tumor) Profiling Major Product Offerings
7.9.4 Oxford Gene Technology Cancer (Tumor) Profiling Revenue in Global Market (2018-2023)
7.9.5 Oxford Gene Technology Key News & Latest Developments
7.10 Ribomed Biotechnologies
7.10.1 Ribomed Biotechnologies Company Summary
7.10.2 Ribomed Biotechnologies Business Overview
7.10.3 Ribomed Biotechnologies Cancer (Tumor) Profiling Major Product Offerings
7.10.4 Ribomed Biotechnologies Cancer (Tumor) Profiling Revenue in Global Market (2018-2023)
7.10.5 Ribomed Biotechnologies Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
